HemAware

Featured On HemAware

Recent Articles

Like thousands of other people with hemophilia A, 17-year-old Sean O’Connor lacks the genetic machinery to produce a working version...
In January 2009, the US Food and Drug Administration (FDA) approved CSL Behring’s RiaSTAP™ for the treatment of acute bleeding...
Hogan Lust started walking last month. He’s two and a half years old. For the tow-headed toddler from Tucson, that...
Update, January 2014: On December 23, 2013, the FDA approved Tretten, Coagulation Factor XIII A-Subunit (Recombinant), which is the first...
 
Paid Advertisement. NBDF does not endorse products or manufacturers.
Chat Icon
Need Information about Bleeding Disorders?
Contact The Neil Frick Resource Center (NFRC)